# Efficacy and Safety of Calculus Bovis Sativus (CBS) for Ischemic Cerebral Vascular Disease (CBSinICVD)

> **NCT06474507** · NA · RECRUITING · sponsor: **Tongji Hospital** · enrollment: 230 (estimated)

## Conditions studied

- Ischemic Cerebrovascular Disease
- Acute Ischemic Stroke
- Cerebral Small Vessel Diseases

## Interventions

- **DRUG:** Calculus bovis sativus (CBS)

## Key facts

- **NCT ID:** NCT06474507
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-08
- **Primary completion:** 2029-07
- **Final completion:** 2029-12
- **Target enrollment:** 230 (ESTIMATED)
- **Last updated:** 2024-09-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06474507

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06474507, "Efficacy and Safety of Calculus Bovis Sativus (CBS) for Ischemic Cerebral Vascular Disease (CBSinICVD)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06474507. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*